Literature DB >> 25278547

Screening for CKD: a pro and con debate.

Alan S Kliger1.   

Abstract

Keywords:  CKD; population testing; screening

Mesh：

Year:  2014        PMID： 25278547      PMCID： PMC4220768          DOI： 10.2215/CJN.08990914

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-10-16       Impact factor: 25.391

2.  Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers.

Authors:  Karsten Juhl Jørgensen
Journal:  Evid Based Med       Date:  2012-08-25

3.  Routine screening for CKD should be done in asymptomatic adults... selectively.

Authors:  Jeffrey S Berns
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-18       Impact factor: 8.237

4.  The paucity of evidence supporting screening for stages 1-3 CKD in asymptomatic patients with or without risk factors.

Authors:  Amir Qaseem; Timothy J Wilt; Molly Cooke; Thomas D Denberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-18       Impact factor: 8.237

5.  Application of the 2013 American Urological Association early detection of prostate cancer guideline: who will we miss?

Authors:  Gregory B Auffenberg; Joshua J Meeks
Journal:  World J Urol       Date:  2014-06-20       Impact factor: 4.226

6.  Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Robert H Hopkins; Donna E Sweet; Melissa Starkey; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-12-17       Impact factor: 25.391
  6 in total
  3 in total

1.  Community-Based CKD Screening in Black Americans.

Authors:  Keith C Norris; Susanne B Nicholas
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 8.237

2.  Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.

Authors:  Nicola Schieda; Jason I Blaichman; Andreu F Costa; Rafael Glikstein; Casey Hurrell; Matthew James; Pejman Jabehdar Maralani; Wael Shabana; An Tang; Anne Tsampalieros; Christian B van der Pol; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2018-06-12

3.  Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.

Authors:  Ikechi G Okpechi; Fergus J Caskey; Abduzhappar Gaipov; Elliot K Tannor; Laura N Hamonic; Gloria Ashuntantang; Jo-Ann Donner; Ana Figueiredo; Reiko Inagi; Magdalena Madero; Charu Malik; Monica Moorthy; Roberto Pecoits-Filho; Vladimir Tesar; Adeera Levin; Vivekanand Jha
Journal:  BMJ Open       Date:  2021-12-16       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.